Guest: Bryan Witherbee, President and CEO, Adarza BioSystems
In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at Clarivate, speaks with Bryan Witherbee, President & CEO of Adarza BioSystems. Earlier this year, Adarza raised 25 million dollars to support the full commercialization of Ziva, an automated biological platform which delivers comprehensive, high definition, protein biomarker profiles. Although their launch plans were disrupted by the pandemic, Bryan shares how Adarza responded to the challenge by utilizing Ziva for COVID-19 research. Learn more in the full episode.
About our guest
Bryan joined Adarza BioSystems in January of 2017 to provide leadership as Adarza transitions from a technology developer to a commercial technology provider. Bryan’s career has spanned scientific, business development, and senior leadership positions in large research institutions and early stage startups in pharma, ag biotech, and life science technologies. He brings many years of experience with a successful track record in developing and commercializing new technologies.
Bryan’s career started at Sigma Diagnostics where he developed and commercialized clinical immunoassays and coagulation reagents. Over the next 20 years he held various R&D leadership roles at Monsanto and Pfizer. He most recently served as Scientific Leader within the Genomics Division at Becton Dickinson (BD) where he provided leadership for the successful commercial launch of solutions for NextGen Sequencing and single cell genomics. Prior to that he was CSO at GenCell Biosystems, which was acquired by BD in 2014.
His key accomplishments include identification and implementation of microfluidic technologies for molecular biology applications, frozen cell technologies, and various high throughput multiplexing technologies for systems biology. Bryan has a BS in Biochemistry from Truman State University.
About our host
Mike Ward serves as Global Head of Thought Leadership at Clarivate. As both a journalist and analyst, Mike has been writing, analyzing and commenting on the life sciences industry for more than 35 years. He has held editorial and content leadership roles at various publications and organizations across the industry.